Sonoma Pharmaceuticals, Inc.
SNOA
$2.97
$0.051.71%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 16.38% | -52.13% | 46.63% | -7.12% | -23.21% |
| Total Depreciation and Amortization | -6.06% | -5.71% | -10.26% | -4.88% | -8.89% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7,633.33% | -124.00% | -91.20% | 879.31% | -67.05% |
| Change in Net Operating Assets | -86.49% | 62.17% | 1,082.61% | -108.01% | 409.70% |
| Cash from Operations | -116.81% | 59.60% | 138.82% | -700.00% | 113.77% |
| Capital Expenditure | -2,250.00% | 92.31% | -420.00% | -127.78% | 1,900.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -2,250.00% | 92.31% | -420.00% | -127.78% | 1,900.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 1.22% | 32.79% | -2.52% | -26.60% | 26.56% |
| Issuance of Common Stock | -93.80% | -49.59% | 107.55% | 120.12% | -76.20% |
| Repurchase of Common Stock | -- | 100.00% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -65.82% | -50.97% | 127.04% | 2.25% | -52.81% |
| Foreign Exchange rate Adjustments | 133.63% | 60.07% | -9.69% | -268.57% | -225.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -88.08% | -22.23% | 376.25% | -174.65% | 168.40% |